Skip to content

TYRA

Tyra Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$28.65
+15.25%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+6.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 1, 2026Gulfo Adele M. · directorA-Award13,160$33
Jun 1, 2026MORE ROBERT J · directorA-Award13,160$33
Jun 1, 2026Rothenberg Stephen Michael · directorA-Award13,160$33
Jun 1, 2026Simson Jake · directorA-Award13,160$33
Jun 1, 2026Moran Susan · directorA-Award13,160$33
Jun 1, 2026Verjee Rehan · directorA-Award13,160$33
Jun 1, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: A-Award13,160$33
May 7, 2026Warner Douglas J · officer: Chief Medical OfficerA-Award25,000$0.00
May 7, 2026Fuhrman Alan · officer: Chief Financial OfficerA-Award20,000$0.00
May 7, 2026Fuhrman Alan · officer: Chief Financial OfficerA-Award67,000$34
May 7, 2026Harris Todd · director, officer: President and CEOA-Award79,000$0.00
May 7, 2026Harris Todd · director, officer: President and CEOA-Award265,000$34
May 7, 2026Ashar Bhavesh · officer: Chief Operating OfficerA-Award15,013$0.00
May 7, 2026Ashar Bhavesh · officer: Chief Operating OfficerA-Award50,295$34
May 7, 2026Warner Douglas J · officer: Chief Medical OfficerA-Award85,000$34
May 7, 2026Rueb Yuliya · officer: Vice President, Finance (PAO)A-Award8,333$0.00
May 7, 2026Rueb Yuliya · officer: Vice President, Finance (PAO)A-Award28,000$34
Apr 20, 2026Dable Habib J · directorA-Award44,400$35
Mar 27, 2026KAPLAN GILLA · directorSale14,295$37
Mar 27, 2026KAPLAN GILLA · directorM-Exempt53,172$2.25
Mar 27, 2026KAPLAN GILLA · directorM-Exempt14,295$2.25
Mar 17, 2026Fuhrman Alan · officer: Chief Financial OfficerA-Award1,376$9.13
Mar 17, 2026Harris Todd · director, officer: President and CEOA-Award1,463$9.13
Feb 13, 2026Bensen Daniel · officer: Chief Discovery OfficerSale2,128$32
Feb 13, 2026Bensen Daniel · officer: Chief Discovery OfficerSale5,872$33
Jan 20, 2026Bensen Daniel · officer: Chief Discovery OfficerSale6,983$28
Jan 20, 2026Bensen Daniel · officer: Chief Discovery OfficerSale1,017$29
Dec 19, 2025MORE ROBERT J · directorSale10,000$25
Dec 16, 2025Bensen Daniel · officer: Chief Discovery OfficerSale8,000$23
Dec 1, 2025Ashar Bhavesh · officer: Chief Operating OfficerA-Award300,000$21
Institutional positioning

13F filings over the trailing two quarters

New 80Increased 135Reduced 80Sold out 24
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged12,198,625Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged12,198,625May 15, 2026
FMR LLCIncreased8,920,513Aug 13, 2026
FMR LLCIncreased7,747,648May 15, 2026
Jupiter Topco LLCNew Position4,352,448Aug 14, 2026
NEXTECH INVEST, LTD.Unchanged4,055,861May 15, 2026
JANUS HENDERSON GROUP PLCIncreased3,890,589May 18, 2026
Alta Partners Management Company, L.P.Unchanged3,823,425Jul 22, 2026
ALTA PARTNERS MANAGEMENT COMPANY, L.P.Unchanged3,823,425Apr 21, 2026
FARALLON CAPITAL MANAGEMENT LLCIncreased3,580,818May 15, 2026
Nextech Invest, Ltd.Reduced3,553,585Aug 14, 2026
TCG CROSSOVER MANAGEMENT, LLCIncreased3,248,980May 15, 2026
TCG Crossover Management, LLCUnchanged3,248,980Aug 14, 2026
BlackRock, Inc.Increased3,031,972Aug 7, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased2,782,567Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 1, 2026